Peptides bound to major histocompatibility complex molecules

Peptides

Volumn 19, Issue 1, 1998, Pages 179-198

  Maffei, Antonella ^a   Harris, Paul E ^a,b  

^a INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^b Coll Phys Surgs of Columbia Univ ^*  (United States)

Author keywords

Antigen processing; HLA; Self peptides

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN; PEPTIDE DERIVATIVE; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; HUMAN; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; CELL MEMBRANE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDES; PROTEIN PRECURSORS; T-LYMPHOCYTES;

EID: 0031939308     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(97)00277-5     Document Type: Review

References (182)

1. Abdel-Motal U. M., Zhou X., Joki A., Siddigi A. ; R.; Srinivasa, B. R.; Stenvall, K.; Dahmen, J.; Jondal. M. Major histocompatibility complex class I-binding peptides are recycled to the cell surface after internalization. Eur. J. Immunol. 23:1993;3224-3229.
2. Aggarwal A., Kumar S., Jaffe R., Hone D., Gross M., Sadoff J. Oral salmonella; malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med. 172:1990;1083-1090.
3. Aldovini A., Young R. A. Huoral and cell-mediated immune responses to live recombinant BCG-HIV vaccines. Nature. 351:1991;479-482.
4. Amigorena S., Drake J. R., Wbster P., Mellman I. Transient accumulation of new class II molecules in a novel endocytic compartment in B lymphocytes. Nature. 369:1994;113-120.
5. Anderson K. S., Miller I. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA. 89:1992;2282-2286.
6. Anderson K. S., Cresswell P. A role for calnexin (IP90) in the assembly of class II MHC molecules. EMBO J. 13:1994;675-682.
7. Andrews N. W. From lysosomes into the cytosol the intracellular pathway of Trypanosoma cruzi . Braz. J. Med. Biol. Res. 27:1994;471-475.
8. Androlewicz M. J., Creswell P. How selective is the transporter associated with antigen processing. Immunity. 5:1996;1-7.
9. Armandola E. A., Momburg F., Nijenhuis M., Bulbuc N., Fruh K., Hammerling G.J. A point mutation in the human transporter associated with antigen processing (TAP2) alters the peptide transport specificity. Eur. J. Immunol. 26:1996;1748-1755.
10. Bacik I., Cox J. H., Anderson R., Yewdell J. W., Bennink J. R. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J. Immunol. 152:1994;381-387.
11. Bakke O., Dobberstein B. MHC class II associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:1990;707-716.
12. Balow J. P., Weissman J. D., Kearse K. P. Unique expression of major histocompatibility complex class I proteins in the absence of glucose trimming and calnexin association. J. Biol. Chem. 270:1995;29025-29029.
13. Bennett K., Levine T., Ellis J. S., Peanasky R. J., Samloff I.M., Kay J., Chain B.M. Antigen processing for presentation by class II MHC requires cleavage by cathepsin D. Eur. J. Immunol. 22:1992;1519-1525.
14. Bennik J. R., Yewdell J. W., Gerhard W. A viral polymerase involved in recognition of influenza viris infected cells by a cytotoxic T clone. Nature. 269:1982;75-77.
15. Bergeron J. J., Brenner M. B., Thomas D. Y., Williams D. B. Calnexin a membrane-bound chaperone of the endoplasmic reticulum . Trends Biochem. Sci. 19:1994;124-128.
16. Bevan, M. J. Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283-1228; 1976.
17. Bijlmakers M. J., Benaroche P., Plough H. L. Assembly of HLA DR molecules translated in vitro binding of peptide in the endoplasmic reticulum precludes association with invariant chain . EMBO J. 13:1994;2699-2707.
18. Bodmer, J. G.; Marsh, S. G. E.; Albert, E. D.; Bodmer, W. F.; Bontrop, R. E.; Charron, D.; Dupont, B.; Erlich, H. A.; Fauchet, R.; Mach, B.; Mayr, W. R.; Parham, P.; Sasazuki, T.; Schreuder, G. M. T.; Strominger, J. L.; Svejgaard, A.; Terasaki, P. I. Nomenclature for factors of the HLA system, 1996. Hum. Immunol. 1997 (in press).
19. Bohm W., Schirmbeck R., Elbe A., Melber K., Diminky D., Kraal G., van Rooijen N., Barenholz Y., Reimann J. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J. Immunol. 155:1995;3313-3321.
20. Bonifacino J. S., Lippincott-Schwartz J. Degradation of proteins within the endoplasmic reticulum. Curr. Opin. Cell Biol. 3:1991;592-600.
21. Bonifacino J. S., Suzuki C. K., Klausner R. D. A peptide sequence confers retention and rapid degradation in the endoplasmic reticulum. Science. 247:1990;79-82.
22. Bonnerot C., Marks M. S., Cosson P., Robertson E., Bikoff E. K., Germain R. N., Bonifacino J. S. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. EMBO J. 13:1994;934-944.
23. Borkman P. J., Parham P. Structure, function and diversity of class I major histocompatibility complex molecules. Ann. Rev. Biochem. 59:1990;253-288.
24. Bouvier M., Wiley D. C. Importance of peptide amino and carboxyl terminii to the stability of peptide binding. Science. 265:1994;398-402.
25. Bresnahan, P. A.; Barber, L. D.; Brodsky, F. Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. Hum. Immunol. 1997 (in press).
26. Brown J. H., Jardetzky T., Saper M. A., Samraoui B., Bjorkman P. J., Wiley D. C. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules. Nature. 332:1988;845-849.
27. Castellino F., Germain R. N. Extensive trafficking of MHC class II - invariant chain complexes in the endocytic pathway and the appearance of peptide-loaded class II in multiple compartments. Immunity. 2:1995;75-88.
28. Cerundolo V., Benham A., Braud V., Mukherjee S., Gould K., Macino B., Neeffjes J., Townsend A. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur. J. Immunol. 27:1997;336-341.
29. Chang H. L., Terlecky S. R., Plant C. P., Dice J. F. A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins. Science. 246:1989;382-385.
30. Chiang H. L., Dice J. F. Peptide sequences that target proteins for enhanced degradation during serum withdrawal. J. Biol. Chem. 263:1988;6797-6805.
31. Chicz R. M., Urban R. G., Gorga J. C., Vignali D. A. A., Lane W. S., Strominger J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 178:1993;27-47.
32. Chicz R. M., Urban R. G., Lane W. S., Gorga J. C., Stern L. J., Vignali D. A. A., Strominger J. L. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature. 358:1992;764-766.
33. Ciechanover A., DiGiuseppe J. A., Bercovich B., Orian A., Richter J. D., Schwartz A. L., Brodeur G. M. Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;139-143.
34. Collins E. J., Garboczi D. N., Wiley D. C. Three-dimensional structure of a peptide extending from one end of a class I MHC binding site. Nature. 371:1994;626-629.
35. Colovai A. I., Suciu-Foca N., Baiulescu G. E., Harris P. E. HLA-class I self peptides isolated from a T cell leukemia reveal the allele-specific motif of HLA-B38. Tissue Antigens. 44:1994;65-72.
36. da Conceicao-Silva F., Perlaza B. L., Louis J. A., Romero P. Leishmania major infection in mice primes for specific major histocompatibility complex class I-restricted CD8+ cytotoxic T cell responses. Eur. J. Immunol. 24:1994;2813-2817.
37. David V., Hochstenbach F., Rajagopalan S., Brenner M. B. Interaction with newly synthesized and retained proteins in the endoplasmic reticulum suggests a chaperone function for human integral membrane protein IP90 (calnexin). J. Biol. Chem. 268:1993;9585-9592.
38. Debrick J. E., Campbell P. A., Staerz U. D. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147:1991;2846-2851.
39. del Guercio M. F., Sidney J., Hermanson G., Perez C., Grey H. M., Kubo R. T., Sette A. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J. Immunol. 154:1995;685-693.
40. DeMars R., Rudersdorf R., Chang C., Petersen J., Strandtmann J., Korn N., Sidwell B., Orr H. T. Mutations that impair a post-transcriptional step in expression of HLA-A and -B antigens. Proc. Natl. Acad. Sci. USA. 82:1985;8183-8187.
41. Demotz S., Barbey C., Corradin G., Amoroso A., Lanzavecchia A. The set of naturally processed peptides displayed by Dr molecules is tuned by polymorphism of residue 86. Eur. J. Immunol. 23:1993;425-434.
42. Denzin L. K., Cresswell P. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell. 82:1995;155-165.
43. DiBrino M., Tsuchida T., Turner R. V., Parker K. C., Coligan J. E., Biddison W. E. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J. Immunol. 151:1993;5930-5935.
44. Dice J. F. Selective degradation of cytosolic proteins by lysosomes. Ann. NY Acad. Sci. 674:1992;58-64.
45. Dick T. P., Ruppert T., Groettrup M., Kloetzel P. M., Kuehn L., Koszinowski U. H., Stevanovic S., Schild H., Rammensee H. G. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell. 86:1996;253-262.
46. Elliott T., Willis A., Cerundolo V., Townsend A. Processing of major histocompatibility class I-restricted antigens in the endoplasmic reticulum. J. Exp. Med. 181:1995;1481-1491.
47. Elliott E. A., Drake J. R., Amigorena S., Elsemore J., Webster P., Mellman I., Flavell R. A. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:1994;681-694.
48. Falk K., Rotzschke O. Consensus motifs and peptide ligands of MHC class I molecules. Semin. Immunol. 5:1993;81-88.
49. Falk K., Rotzschke O., Stevanovic S., Jung G., Rammensee H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290-295.
50. Finley D., Bartel B., Varshavsky A. The tails of ubiquitin precursors are ribosomal proteins whose fusion to ubiquitin facilitates ribosome biogenesis. Nature. 338:1989;394-401.
51. Finley D., Chau V. Ubiquitination. Ann. Rev. Cell Biol. 7:1991;25-69.
52. Fling S. P., Arp B., Pious D. HLA-DMA and -DMB genes are both required for MHC class II / peptide complex formation in antigen-presenting cells. Nature. 368:1994;554-558.
53. Freisewinkel I. M., Scenck K., Koch N. The segment of invariant chain that is critical for association with major histocompatibility complex class II molecules contains the sequence of a peptide eluted from class II polypeptides. Proc. Natl. Acad. Sci. USA. 90:1993;9703-9706.
54. Frumento G., Harris P. E., Gawinowics M. A., Suciu-Foca N., Pernis B. Sequence of a prominent 16 residue self-peptide bound to HLA-B27 in a lymphoblastoid cell line. Cell Immunol. 152:1993;623-626.
55. Gaczynska M., Rock K. L., Spies T., Goldberg A. L. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc. Natl. Acad. Sci. USA. 91:1994;9213-9217.
56. Gardner A. M., Aviel S., Argon Y. Rapid degradation of an unassembled immunoglobulin light chain is mediated by a serine protease and occurs in a pre-Golgi compartment. J. Biol. Chem. 268:1993;25940-25947.
57. Garret T. P. J., Saper M. A., Bjorkman P. J., Strominger J. L., Wiley D. C. Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature. 342:1989;692-694.
58. Germain R. N., Rinker A. G. Peptide binding inhibits protein aggregation of invariant chain-free class II dimers and promotes surface expression of occupied molecules. Nature. 363:1993;725-727.
59. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Ann. Rev. Immunol. 11:1993;403-450.
60. Gonen H., Smith C. E., Siegel N. R., Kahana C., Merrick W. C., Chakraburtty K., Schwartz A. L., Ciechanover A. Protein synthesis elongation factor EF-1 alpha is essential for ubiquitin-dependent degradation of certain N alpha-acetylated proteins and may be substituted for by the bacterial elongation factor EF-Tu. Proc. Natl. Acad. Sci. USA. 91:1994;7648-7652.
61. Goodling L. R., O'Connell K. A. Recognition by cytotoxic T lymphocytes of cells expressing fragments of the SV40 tumor antigen. J. Immunol. 131:1983;2580-2586.
62. Gorga J. C. Structural analysis of class II major histocompatibility complex proteins. Crit. Rev. Immunol. 11:1992;305-323.
63. Grandea A. G. III, Androlewicz M. J., Athwal R. S., Geraghty D. E., Spies T. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science. 270:1995;105-108.
64. Groettrup M., Soza A., Kuckelkorn U., Kloetzel P. Peptide antigen production by the proteasome complexity provides efficiency . Immunol. Today. 17:1996;429-435.
65. Groettrup M., Kraft R., Kostka S., Standera S., Stohwasser R., Kloetzel P. M. A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur. J. Immunol. 26:1996;863-869.
66. Groettrup M., Soza A., Eggers M., Kuehn L., Dick T. P., Schild H., Rammensee H. G., Koszinowski U. H., Kloetzel P. M. A role for the proteasome regulator PA28 alpha in antigen presentation. Nature. 381:1996;166-168.
67. Gueguen M., Long E. O. Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. Proc. Natl. Acad. Sci. USA. 93:1996;14692-14697.
68. Guo H.-C., Jardetzky T. S., Garrett T. P. J., Lane W. S., Strominger J. L., Wiley D. C. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature. 360:1992;364-366.
69. Hammond C., Helenius A. Quality control in the secretory pathway. Curr. Opin. Cell Biol. 7:1995;523-529.
70. Harding C. V., Song R. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:1994;4925-4933.
71. Harding C. V., France J., Song R., Farah J. M., Chatterjee S., Iqbal M., Siman R. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J. Immunol. 155:1995;1767-1775.
72. Harding C. V., Geuze H. J. Immunogenic peptides bind to class II MIIC molecules in an early lysosomal compartment. J. Immunol. 151:1993;3988-3998.
73. Harding, C. V.; Collins, D. S.; Slot, J. W.; Geuze, H. J.; Unanue, E. R. Liposome incapsulated antigens are processed in lysosomes, recycled and presented to T cells. Cell 64:393-348; 1991.
74. Harding C. V., Roof R. W., Allen P. M., Unanue E. R. Effect of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA. 88:1991;2740-2748.
75. Harris P. E., Colovai A. I., Maffei A., Liu Z., Suciu-Foca N. MHC class I presentation of exogenous and endogenous protein-derived peptides by a transfected human monocyte cell line. Immunology. 86:1995;601-611.
76. Harris P. E., Maffei A., Colovai A. I., Kinne J., Tugulea S., Suciu-Foca N. MHC class II presentation of intracellular protein derived self peptides by a human myeloid progenitor cell line. Blood. 87:1996;1105-1112.
77. Harris P. E., Maffei A., Colovai A. I., Liu Z., Suciu-Foca N. Naturally processed cytokine derived peptide bound to MHC class II molecules. J. Immunol. 151:1993;5975-5983.
78. Harris P. E., Colovai A. I., Liu Z., Dalla-Favera R., Suciu-Foca N. Naturally processed MHC class I bound peptides from c-myc transfected B cells reveal alele specific motifs. J. Immunol. 151:1993;5966-5974.
79. Harris P. E., Lupu F., Hong B., Reed E. F., Suciu-Foca N. Differentiation stage specific "self" peptides bound by MHC-class I molecules. J. Exp. Med. 177:1993;783-790.
80. Heemels M. T., Ploegh H. Generation, translocation and presentation of MHC class I-restricted peptides. Ann. Rev. Biochem. 64:1995;463-491.
81. Hill C. M., Hayball J. D., Allison A. A., Rothbard J. B. Conformational and structural characteristics of peptides binding to HLA-DR molecules. J. Immunol. 147:1991;189-197.
82. Hisamatsu H., Shimbara N., Saito Y., Kristensen P., Hendil K. B., Fujiwara T., Takahashi E., Tanahashi N., Tamura T., Ichihara A., Tanaka K. Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma. J. Exp. Med. 183:1996;1807-1816.
83. Huczko, E. L.; Bodnar, W. M.; Benjamin, D.; Sakaguchi, K.; Zhu, N. Z.; Shabinowitz, J.; Henderson, R. A.; Appella, E.; Hunt, D. F.; Engelhard, V. H. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modelling. J. Immunol. 151:2572-2258; 1993.
84. Hughes E. A., Ortmann B., Surman M., Cresswell P. The protease inhibitor, N-acetyl-L-leucyl-L-leucyl-leucyl-L-norleucinal, decreases the pool of major histocompatibility complex class I-binding peptides and inhibits peptide trimming in the endoplasmic reticulum. J. Exp. Med. 183:1996;1569-1578.
85. Hunt D. F., Henderson R. A., Shabanowicz J., Sakaguchi K., Michel H., Sevilir N., Cox A., Appella E., Engelhard V. H. Characterization of peptides bound to class I MHC molecules HLA A2.1 by mass spectrometry. Science. 255:1992;1261-1263.
86. Isenman L. D., Dice J. F. Secretion of intact proteins and peptide fragments by lysosomal pathways of protein degradation. J. Biol. Chem. 264:1989;21591-21596.
87. Jaraquemada D., Marti M., Long E. O. An endogenous processing pathway in vaccina virus-infected cells for the presentation of cytoplasmic antigens to class II restricted T cells. J. Exp. Med. 172:1990;947-956.
88. Jardetzky T. S., Lane W. S., Robinson R. A., Madden D. R., Wiley D. C. Identification of self-peptides bound to purified HLA-B27. Nature (London). 353:1991;326-328.
89. Jensen P. E. Long-lived complexes between peptide and class II major histocompatibility complex molecules are formed at low pH with no requirement for pH neutralization. J. Exp. Med. 176:1992;793-802.
90. Jones P. P., Murphy D. B., Hewgill D., McDevitt H. O. Detection of a common polypeptide chain inI-A and I-E sub-region immunoprecipitates. Mol. Immunol. 16:1979;51-58.
91. Kaleab B., Ottenoff T., Converse P., Halapi E., Tadesse G., Rottenberg M., Kiessling R. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur. J. Immunol. 20:1990;2651-2659.
92. Kleijmeer M. J., Kelly A., Geuze H. J., Slot J. W., Townsend A., Trowsdale J. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi. Nature. 357:1992;342-344.
93. Koopmann J. O., Post M., Neefjes J. J., Hammerling G. J., Momburg F. Translocation of long peptides by transporters associated with antigen processing (TAP). Eur. J. Immunol. 26:1996;1720-1728.
94. Kovacsovics-Bankowski M., Rock K. L. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science. 267:1995;243-246.
95. Kubo R. T., Sette A., Grey H. M., Appeila E., Sakaguchi K., Arnott D., Sherman N., Shabonowitz J., Michel H., Bodnar W. M., Davis T. A., Hunt D. F. Definition of specific peptide motifs for four major HLA-A alleles. J. Immunol. 152:1994;3913-3924.
96. Kvist S., Wiman K., Claesson L., Peterson P., Dobberstein B. Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens. Cell. 29:1982;61-72.
97. Lippincott-Schwartz J., Bonifacino J. S., Yuan L., Klausner R. D. Degradation from the endoplasmic reticulum disposing of newly synthesized proteins . Cell. 54:1988;209-220.
98. Lopez de Castro J. A., Bragado R., Strong D. M., Strominger J. L. Primary structure of papain-solubulized human histocompatibility antigen HLA-B40(Bw60) an outline of alloantigenic determinants . Biochemistry. 22:1983;3961-3969.
99. Lotteau V., Teyton L., Peleraux A., Nisson T., Karisson L., Schmid S. L., Quaranta V., Peterson P. A. Intracellular transport of class II MHC molecules directed by invariant chain. Nature. 348:1990;600-605.
100. Madden D. R. The three-dimensional structure of peptide-MHC complexes. Ann. Rev. Immunol. 13:1995;587-622.
101. Madden D. R., Gorga J. C., Strominger J. L., Wiley D. C. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1992;1035-1042.
102. Malnati M. S., Marti M., La Vaute T., Jaraquemada D., Biddison W., DeMars R., Long E. O. Processing pathways for presentation of cytosolic antigens to MHC class II restricted T cells. Nature. 257:1992;702-704.
103. Marzella, L.; Glaumann, H. Lysosomes: their role in protein breakdown. London: Academic; 1987; 319-367.
104. Matthews J. R., Hay R. T. Regulation of the DNA binding activity of NF-kappa B. Int. J. Biochem. Cell Biol. 27:1995;865-879.
105. Mayer R. J., Lowe J., Landon M., McDermott H., Tuckwell J., Doherty F., Laszlo L. Ubiquitin and the lysosome system molecular immunopathology reveals the connection . Biomed. Biochim. Acta. 50:1991;333-341.
106. Mellins E., Smith L., Arp B., Cotner T., Celis L., Pious D. Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes. Nature. 343:1990;71-74.
107. Mitchell H. K., Petersen N. S., Buzin C. H. Self-degradation of heat shock proteins. Proc. Natl. Acad. Sci. USA. 82:1985;4969-4973.
108. Momburg F., Roelse J., Howard J. C., Butcher G. W., Hammerling G. J., Neefjes J. J. Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature. 367:1994;648-651.
109. Monaco J. J. A molecular model of MHC class-I-restricted antigen processing. Immunol. Today. 13:1992;173-179.
110. Moore M. W., Carbone F. R., Bevan M. J. Introduction of soluble protein into class I pathway of antigen presentation. Cell. 54:1988;777-788.
111. Morrison L. A., Lukacher A., Braciale V. L., Fan D. P., Braciale T. J. Differences in an antigen presentation to MHC class I and class II restricted influenza virus specific T lymphocyte clones. J. Exp. Med. 163:1986;903-999.
112. Mouritsen S., Hansen A. S., Petersen B. L., Buus S. pH dependence of the interaction between immunogenic peptides and MHC molecules evidence for an acidic intracellular compartment being the organelle of interaction . J. Immunol. 148:1992;1438-1491.
113. Muller S., Schwartz L. M. Ubiquitin in homeostasis, development and disease. Bioessays. 17:1995;677-684.
114. Musti A. M., Treier M., Bohman D. Reduced ubiquitin-dependent degradation of c-Jun after phosphorylation by MAP kinases. Science. 275:1997;400-402.
115. Nair S., Buiting A. M., Rouse R. J., Van Rooijen N., Huang L., Rouse B. T. Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses. Int. Immunol. 7:1995;679-688.
116. Neefjes J. J., Momburg F., Hammerling G. J. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science. 621:1993;769-771.
117. Neefjes J. J., Smit L., Gehrmann M., Ploegh H. L. The fate of the three subunits of major histocompatibility complex class I molecules. Eur. J. Immunol. 22:1992;1609-1614.
118. Neefjes J. J., Stollorz V., Peters P. J., Geuze H. J., Ploegh H. L. The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route. Cell. 61:1990;171-183.
119. Neisig A., Wubbolts R., Zang X., Melief C., Neefjes J. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:1996;3196-3206.
120. Norbury C. C., Hewlett L. J., Prescott A. R., Shastri N., Watts C. Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity. 3:1995;783-791.
121. Nuchtern J. G., Biddison W. E., Klausner R. D. Class II molecules can use the endogenous pathway of antigen presentation. Nature. 343:1990;74-78.
122. Obst R., Armandola E. A., Nijenhuis M., Momburg F., Hammerling G. J. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur. J. Immunol. 25:1995;2170-2176.
123. Ortmann B., Androlewicz M. J., Cresswell P. MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature. 368:1994;864-867.
124. Papadopoulos K. P., Colovai A. I., Maffei A., Jaraquemada D., Suciu-Foca N., Harris P. E. Tissue-specific MHC class I bound self peptides of a human insulinoma cell line. Diabetes. 45:1996;1761-1765.
125. Parag R. A., Shochat Y., Kulka R. G. Effect of stress on protein degradation role of the ubiquitin system . Acta Biologica Hungarica. 42:1991;3-20.
126. Parker K. C., Shields M., DiBrino M., Brooks A., Coligan J. E. Peptide binding to MHC class I molecules implications for antigenic peptide prediction . Immunol. Res. 14:1995;34-57.
127. Parker K. C., Bednarek M. A., Coligan J. E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J. Immunol. 152:1994;163-175.
128. Pfeifer J. D., Wick M. J., Harding C. V., Normark S. J. Processing of defined T-cell epitopes after phagocytosis of intact bacteria by macrophages. Infect. Agents Dis. 2:1993;249-254.
129. Pfeifer J. D., Wick M. J., Roberts R. L., Findlay K., Normark S. J., Harding C. V. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature. 361:1993;359-362.
130. Pierce S. K., DeNagel D. C., Van-Buskirk A. M. A role for heat shock proteins in antigen processing and presentation. Curr. Top. Microbiol. Immunol. 167:1991;83-97.
131. Rammensee H. G., Friede T., Stevanovic S. MHC ligands and peptide motifs. First listing. Immunogenetics. 41:1995;178-228.
132. Raposo G., van Santen H. M., Leijendekker R., Geuze H., Ploegh H. L. Misfolded major histocompatibility complex class I molecules accumulate in an expanded ER-Golgi intermediate compartment. J. Cell Biol. 131:1995;1403-1419.
133. Redman K. L., Burris G. W. The cDNA for the ubiquitin-52-amino-acid fusion protein from rat encodes a previously unidentified 60S ribosomal subunit protein. Biochem J. 315:1996;315-321.
134. Redman K. L. The smaller protein formed as a ubiquitin fusion in Drosophila is processed from ubiquitin and found on the 60S ribosomal subunit. Ins. Biochem. Molec. Biol. 24:1994;191-201.
135. Reid P. A., Watts C. Cycling of cell-surface MHC glycoproteins through primaquine-sensitive intracellular compartments. Nature. 346:1990;655-657.
136. Reis e Sousa C., Germain R. N. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J. Exp. Med. 182:1995;841-851.
137. Roche P. A., Marks M. S., Cresswell P. Formation of a nine subunit complex by HLA-class II glycoproteins and the invariant chain. Nature. 354:1991;392-394.
138. Rock K. L. A new foreign policy MHC class I molecules monitor the outside world. Immunol. Today. 17:1996;131-137.
139. Rodriguez G. M., Diment S. Role of cathepsin D in antigen presentation of ovalbumin. J. Immunol. 149:1992;2894-2905.
140. Roelse J., Gromme M., Momburg F., Hammerling G., Neefjes J. Trimming of TAP-translocated peptides in the endoplasmic reticulum and in the cytosol during recycling. J. Exp. Med. 180:1994;1591-1597.
141. Romero P., Maryanski J. L., Corradin G., Nussenzweig R. S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 341:1989;323-326.
142. Rubin D. M., Finley D. The proteasome a protein-degrading organell? Curr. Biol. 5:1995;854-858.
143. Rudensky A. Y., Preston-Hurlburt P. ; Al Ramadi, B. K.; Rothbard, J.; Janeway, C. A., Jr. Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs. Nature (London). 359:1988;429-431.
144. Rudensky A. Y., Preston-Hurlburt P., Hong S. C., Barlow A., Janeway C. A. Jr. Sequence analysis of peptides bound to MHC class II molecules. Nature. 353:1991;622-624.
145. Sadasivan B., Lehner P. J., Ortman B., Spies T., Cresswell P. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. Immunity. 5:1996;103-114.
146. Sadegh-Nasseri S., Germain R. N. A role for peptide in determining MHC class II structure. Nature. 353:1991;167-170.
147. Sant A. J. Endogenous antigen presentation by MHC class II molecules. Immunol. Res. 13:1994;253-267.
148. Saper M. A., Bjorkman P. J., Wiley D. C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6A resolution. J. Mol. Biol. 219:1991;277-288.
149. Schafer R., Portnoy D. A., Brassell S. A., Paterson Y. Induction of a cellular immune response to a foreign antigen by a recombinant Listeria monocytogenes vaccine. J. Immunol. 149:1992;53-59.
150. Schaiff W. T., Hruska K. A. Jr, McCourt D. W., Green M., Schwartz B. D. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells. J. Exp. Med. 176:1992;657-666.
151. Schirmbeck R., Melber K., Reimann J. Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur. J. Immunol. 25:1995;1063-1070.
152. Schirmbeck R., Reimann J. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur. J. Immunol. 24:1994;1478-1486.
153. Schirmbeck R., Reimann J. Peptide transporter-independent, stress protein-mediated endosomal processing of endogenous protein antigens for major histocompatibility complex class I presentation. Eur. J. Immunol. 24:1994;1478-1486.
154. Schumacher T. N. M., Kantesaria D. V., Heemels M.-T., Ashton-Rickardt P. G., Shepherd J. C., Fruh K., Yang Y., Peterson P. A., Tonegawa S., Ploegh H. L. J. Exp. Med. 179:1994;533-540.
155. Scott J. E., Dawson J. R. MHC class I expression and transport in a calnexin-deficient cell line. J. Immunol. 155:1995;143-148.
156. Seglen P. O., Bohley P. Autophagy and other vacuolar protein degradation mechanisms. Experientia. 48:1992;158-164.
157. Seliger B., Hohne A., Knuth A., Bernhard H., Meyer T., Tampe R., Momburg F., Huber C. Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells evidence for deficiencies associated with transformation and progression . Cancer Res. 56:1996;1756-1760.
158. Sette A., Southwood S., O'Sullivan D., Gaeta F. G. A., Sidney J., Grey H. M. Effect of pH on class II peptide interactions. J. Immunol. 148:1992;844-852.
159. Shin J., Lee S., Strominger J. L. Translocation of TCR alpha chains into the lumen of the endoplasmic reticulum and their degradation. Science. 259:1993;1901-1904.
160. Snyder H. L., Yewdell J. W., Bennink J. R. Trimming of antigenic peptides in an early secretory compartment. J. Exp. Med. 180:1994;2389-2394.
161. Song R., Harding C. V. Roles of proteasomes, transporter for antigen presentation (TAP), and beta 2-microglobulin in the processing of bacterial or particulate antigens via an alternate class I MHC processing pathway. J. Immunol. 156:1996;4182-4190.
162. Sonnichsen B., Fullenkrug J., Van P. N., Diekrnann W., Robinson D. J., Mieskes G. Retention and retrieval both mechanisms cooperate to maintain calreticulin in the endoplasmic reticulum . J. Cell Sci. 107:1994;2705-2717.
163. Srivastava P. K., Udono H., Blachere N. E., Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics. 39:1994;93-98.
164. Steinman R. M. The dendritic cell system and its role in immunogenicity. Ann. Rev. Immunol. 9:1991;271-296.
165. Stover C. K., Bansal G. P., Hanson M. S., Burlein J. E., Palaszynski S. R., Young J. F., Koenig S., Young D. B., Sadziene A., Barbour A. G. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein a candidate Lyme disease vaccine . J. Exp. Med. 178:1993;197-209.
166. Sugita M., Brenner M. B. Association of the invariant chain with major histocompatibility complex class I molecules directs trafficking to endocytic compartments. J. Biol. Chem. 270:1995;1443-1448.
167. Suh W. K., Cohen-Doyle M. F., Fruh K., Wang K., Peterson P. A., Williams D. B. Interaction of MHC class I molecules with the transporter associated with antigen processing. Science. 264:1994;1322-1326.
168. Tevethia S. S., Tevethia M. J., Lewis A. J., Reddy V. B., Weimman S. M. Biology of simian virus 40 (SV40) transplantation antigen (TrAg) IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology. 128:1983;319-324.
169. Townsend A. R. M., Skehel J. J. The influenza A virus nucleoprotein gene controls the induction of both sub-type specific and cross-reactive cytotoxic T cell. J. Exp. Med. 160:1984;552-560.
170. Townsend A. R., Bastin J., Gould K., Brownlee G. G. Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature (London). 324:1986;575-579.
171. Tulp A., Verwoerd D., Dobberstein B. ; Ploegh,; H. I.; Pieters, J. Isolation and characterization of the intracellular MHC class II compartment. Nature. 369:1994;120-126.
172. van Endert P. M., Riganelli D., Greco G., Fleischhauer K., Sidney J., Sette A., Bach J. F. The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 182:1995;1883-1895.
173. Varshavsky A. The N-end rule. Cell. 69:1992;725-735.
174. Vassilakos A., Cohen-Doyle M. F., Peterson P. A., Jackson M. R., Williams D. B. The molecular chaperone calnexin facilitates binding and assembly of class I histocompatibility molecules. EMBO J. 15:1996;1495-1506.
175. Vassilev A. P., Rasmussen H. H., Christensen E. I., Nielsen S., Celis J. E. The levels of ubiquitinated histone H2A are highly upregulated in transformed human cells partial colocalization of uH2A clusters and PCNA/cyclin foci in a
176. West M. A., Lucocq I. M., Watts C. Antigen processing and class II MHC peptide-loading compartments in human B lymphoblastoid cells. Nature. 369:1994;147-151.
177. Williams D. B., Watts T. H. Molecular chaperones in antigen presentation. Curr. Opin. Immunol. 7:1995;77-84.
178. Wu J. Y., Gardner B. H., Kushner N. N., Pozzi L. A., Kensil C. R., Cloutier P. A., Coughlin R. T., Newman M. J. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes. Cell. Immunol. 154:1994;393-406.
179. Yang B., Hahn Y. S., Hahn C. S., Braciale T. J. The requirement for proteasome activity class I major histocompatibility complex antigen presentation is dictated by the length of preprocessed antigen. J. Exp. Med. 183:1996;1545-1552.
180. Young J. W., Steinman R. M. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD+ helper T cells. J. Exp. Med. 171:1990;1315-1332.
181. Young J. Y., Kane L. P., Exley M., Wileman T. Regulation of selective protein degradation in the endoplasmic reticulum by redox potential. J. Biol. Chem. 268:1993;19810-19818.
182. Zhou X., Liu T., Franksson L., Lederer E., Ljunggren H. G., Jondal M. Characterization of TAP-independent and brefeldin A-resistant presentation of Sendai virus antigen to CD8+ cytotoxic T lymphocytes. Scand. J. Immunol. 42:1995;66-75.